Low-Spin Iron(III) Porphyrin Complexes
Inorganic Chemistry, Vol. 40, No. 14, 2001 3425
using CH2Cl2 as solvent. EPR spectra were measured at 4.2 K with a
Brucker ESP-300E spectrometer operating at X band and equipped with
an Oxford helium cryostat. The samples for the EPR measurement were
prepared by the addition of 4 to 6 equiv of the ligands into the CH2Cl2
solutions of [Fe(Porphyrin)Cl] or [Fe(Porphyrin)]ClO4. The concentra-
tions of EPR samples were 5∼8 mM. The observed EPR spectra had
enough quality to determine their g values from the spectra except for
some broad signals. In the latter case, the g-values were estimated by
the simulation of the observed spectra using Bruker WIN-EPR Sim
Fonia program.
4.01, 2.00. Mo¨ssbauer (microcrystalline, 80 K): IS ) 0.50 mm s-1
,
QS ) 3.50 mm s-1. SQUID (microcrystalline, µeff): 3.85 ( 0.05 µB in
20∼300 K.40
[Fe(OEP)(THF)2]ClO4.41 1H NMR (CD2Cl2, 25 °C, δ): 10.3(4H,
meso), 34.6(16H, CH2), 6.2(24H, CH3). Coordinated THF ligand
showed very broad signals at 10.3 and 6.0 ppm.
[Fe(ProtoIXMe2)(THF)2]ClO4. 1H NMR (CD2Cl2, 25 °C, δ):
69.3(3H, CH3), 68.4(3H, CH3), 66.6(3H, CH3), 62.5(3H, CH3), 50.5(1H,
vinyl-R), 48.3(1H, vinyl-R), 40.0(2H, R-CH2), 39.5(2H, R-CH2), 6.7(4H,
â-CH2 x 2 ), 3.64(6H, OCH3 x 2), -8.99(1H, vinyl-â), -9.17(1H, vinyl-
â), -10.39(1H, vinyl-â), -10.59(1H, vinyl-â). Broad signals were
observed at 22 and 11 ppm due to the coordinated THF.
[Fe(Porohyrin)(HIm)2]Cl (Porphyrin ) TRP, TPP). These com-
plexes were prepared by the addition of 4 to 6 equiv of imidazole into
a CD2Cl2 solution of [Fe(Porphyrin)Cl] placed in an NMR sample tube
as described in our previous paper.18
n
Synthesis. Free base porphyrins. H2(TRP)(R ) Pr,37 cPr,18 and
iPr29,38), H2(TPP), H2(OMTPP),25 and H2(OETPP),25 were prepared from
the corresponding aldehydes and pyrroles according to the literature.
H2(OEP) and H2(ProtoIXMe2) were purchased from Aldrich. The meso
13C enriched H2(TPP), H2(OMTPP), and H2(OETPP) were prepared
similarly with the use of benzaldehyde-carbonyl-13C (99 atom % 13C)
purchased from Aldrich.
[Fe(F20-TPP)(1-MeIm)2]Cl. This complex was prepared by the
addition of 4 equiv of 1-methylimidazole into a CD2Cl2 solution of
[Fe(F20-TPP)Cl] placed in an NMR sample.1H NMR (CD2Cl2, 25 °C,
δ): -15.9(8H, Py-H), 19.4(6H, CH3), -7.18(2H, ligand).
[Fe(ORTPP)(HIm)2]ClO4 (R ) Me, Et). A large excess of HIm
was necessary for the complete conversion of [Fe(ORTPP)Cl] into [Fe-
(ORTPP)(HIm)2]Cl. Thus, [Fe(ORTPP)-(THF)2]ClO4 was used instead
of [Fe(ORTPP)Cl]. The CD2Cl2 solution of [Fe(ORTPP)-(THF)2]ClO4
was treated with 4 to 6 equiv of HIm in an NMR sample tube.
[Fe(Porphyrin)Cl](Porphyrin ) TRP, TPP, F20-TPP, ORTPP,
OEP, ProtoIXMe2). Insertion of iron was performed using FeCl2‚4H2O
either in refluxing CH3OH-CHCl3 (1:3) for H2(TRP), H2(OEP), and
H2(ProtoIXMe2) or in refluxing DMF for H2(ORTPP).18,28 The Fe(III)
porphyrin complexes thus formed were treated with diluted HCl and
purified by chromatography on silica gel using CH2Cl2-CH3OH as
eluents. Formation of [Fe(TRP)Cl], [Fe(ORTPP)Cl], [Fe(OEP)Cl], and
[Fe(ProtoIXMe2)Cl] was confirmed by the comparison with the UV-
1
vis and H NMR spectral properties reported before.13,18,28,30 [Fe(F20-
1
Formation of [Fe(ORTPP)(HIm)2]ClO4 was confirmed by the H and
13C NMR spectra at 25 °C.
TPP)Cl] was purchased from Aldrich.
[Fe(OMTPP)(HIm)2]ClO4. 1H NMR (CD2Cl2, 25 °C, δ): 21.1(24H,
CH3), 5.42(8H, o), 6.21(8H, m), 6.79(4H, p). The ligand exchange was
[Fe(Porphyrin)(THF)2]ClO4(Porphyrin ) TRP, TPP, F20-TPP,
ORTPP, OEP, ProtoIXMe2). A THF solution (5 mL) of AgClO4 (3.5
× 10-5 mol) was added to a THF solution (20 mL) of [Fe(Por)Cl] (3.5
× 10-5 mol). The solution was stirred for a minute at room temperature
and then evaporated. Caution! Perchlorate salts are potentially
explosiVe when heated or shocked. Handle them in milligram quantities
with care. Dichloromethane (20 mL) was added to the reaction mixture
and the resultant suspension was filtered to remove silver chloride. After
the evaporation of the filtrate, 20 mL of THF was added to dissolve
the solid and then 20 mL of heptane was added. The solution was
allowed to stand overnight. The purple crystal thus formed was collected
by filtration, washed with hexane, and dried in vacuo for 10 min at 25
°C.39
1
fast on the H NMR time scale at 25 °C. As a result, the free and the
coordinated ligands gave broad signals at the average positions. The
ligand exchange became slow below -40 °C to show the coordinated
1
ligand signals separately. H NMR (CD2Cl2, -79 °C, δ): 23.0(24H,
CH3), 1.79(8H, o), 4.39(8H, m), 5.40(4H, p), 20.6(2H, ligand), 13.0(2H,
ligand), -4.6(2H, ligand). 13C NMR (CD2Cl2, 25 °C, δ): 128.4(s, R-Py),
173.0(s, â-Py), -33.4(q, CH3), 28.5(s, meso), 153.4(s, ipso), 116.6(d,
o), 126.4(d, m), 125.9(d, p).
[Fe(OETPP)(HIm)2]ClO4. 1H NMR (CD2Cl2, 25 °C, δ): 4.5(broad,
8H, CH2), ca. 10 (broad, 8H, CH2), 0.86(24H, CH3), 4.96(8H, o),
5.79(8H, m), 6.72(4H, p). The ligand exchange was fast on the 1H NMR
time scale at 25 °C. However, the process was frozen below -20 °C,
1
[Fe(TiPrP)(THF)2]ClO4. Yield: 69%. H NMR (CD2Cl2, 25 °C,
1
δ): -34.8(8H, Py-H), 13.0(4H, meso R-H), 5.0(24H, meso â-H), 4.5(8H,
THF), 9.5(8H, THF). EPR(CH2Cl2, 4.2 K): g ) 3.99, 1.97. Mo¨ssbauer
giving the signals of the coordinated HIm ligand. H NMR (CD2Cl2,
-70 °C, δ): 2.84(8H, CH2), 12.50(8H, CH2), 1.41(24H, CH3), 2.09(8H,
o), 4.31(8H, m), 5.76(4H, p), 22.2(2H, ligand), 17.5(2H, ligand),
14.6(2H, ligand). 13C NMR (CD2Cl2, 25 °C, δ): 162.4(s, R-Py), 167.0(s,
â-Py), -23.5(t, CH2), 86.6(q, CH3), 7.0(s, meso), 164.0(s, ipso); 107.4(d,
o); 124.6(d, m); 125.0(d, p).
(microcrystalline, 76 K): IS ) 0.34 mm s-1, QS ) 3.71 mm s-1
.
SQUID (microcrystalline, µeff): 3.90 ( 0.10 µB in 50 ∼ 300 K.40 The
crystal structure of this complex was reported elswhere.35
1
[Fe(TcPrP)(THF)2]ClO4. Yield: 70%. H NMR (CD2Cl2, 25 °C,
[Fe(Porphyrin)(CN)2]NBu4 (Porphyrin ) TRP, TPP, F20-TPP,
ORTPP). These complexes were prepared by the addition of 4 to 6
equiv of tetrabutylammonium cyanide into a CD2Cl2 solution of [Fe-
(Porphyrin)Cl] placed in an NMR sample tube as described in our
previous papers.13,18 Formation and spectroscopic results of [Fe(TRP)-
(CN)2]NBu4(R ) iPr, cPr, nPr) and [Fe(TPP)(CN)2]NBu4 have already
been reported.13,18, 42,43
δ): -35.3(8H, Py-H), 32.8(4H, meso R-H), 0.89(8H, meso â-H),
2.79(8H, meso â-H), 7.6(8H, THF), 12.5(8H, THF).
1
[Fe(TnPrP)(THF)2]ClO4. Yield: 77%. H NMR (CD2Cl2, 25 °C,
δ): -19.0(8H, Py-H), 15.6(8H, meso R-H), 4.97(8H, meso â-H),
2.86(12H, meso γ-H), 9.5(8H, THF), 14.6(8H, THF).
[Fe(F20-TPP)(THF)2]ClO4. Yield: 65%. 1H NMR (CD2Cl2, 25 °C,
δ): 41.4(8H, Py-H), 7.9(8H, THF), 19.4(8H, THF).
[Fe(F20-TPP)(CN)2]NBu4. 1H NMR (CD2Cl2, 25 °C, δ): -19.4(8H,
1
[Fe(OMTPP)(THF)2]ClO4. Yield: 67%. H NMR (CD2Cl2, -20
Py-H). 13C NMR (CD2Cl2, 25 °C, δ): 48.6(s, R-Py), 92.0(d, â-Py),
°C, δ): 71.5(24H, CH3), 13.8(8H, o), 6.88(8H, m), 10.40(4H, p),
9.4(8H, THF), 13.8(8H, THF). Another signal for the coordinated THF
ligand might be too broad to detect.
2
1
32.9(s, meso), 109.4(t, JC-F ) 18.1 Hz, ipso), 142.8(d, JC-F ) 244
1
1
Hz, o), 134.8(d, JC-F ) 256 Hz, m), 139.7(d, JC-F ) 256 Hz, p).
[Fe(OMTPP)(CN)2]NBu4. 1H NMR (CD2Cl2, 25 °C, δ): 13.36(24H,
CH3), 5.43(8H, o), 7.16 (8H, m), 6.58(4H, p). 13C NMR (CD2Cl2, 25
°C, δ): 85.3(s, R-Py), 127.2(s, â-Py), -23.2 (q, CH3), 136.6(s, meso),
123.2(s, ipso), 166.8(d, o), 131.7(d, m), 127.6(d, p).
[Fe(OETPP)(THF)2]ClO4. Yield: 87%. 1H NMR (CD2Cl2, 25 °C,
δ): 42.7(8H, CH2), 14.2(8H, CH2), 0.67(24H, CH3), 12.9(8H, o),
6.5(8H, m), 10.6(4H, p), 11.4(8H, THF). EPR(CH2Cl2, 4.2 K): g )
[Fe(OETPP)(CN)2]NBu4. 1H NMR (CD2Cl2, 25 °C, δ): 0.78(24H,
(37) Neya, S.; Funasaki, N. J. Heterocycl. Chem. 1997, 34, 689-690.
(38) Wagner, R. W.; Lawrence, D. S.; Lindsey, J. S. Tetrahedron Lett.
1987, 28, 3069-3070.
CH3); 6.87(16H, CH2); 5.39(8H, o); 6.48(8H, m); 6.56(4H, p). 13C NMR
(39) Full report on the formation, characterization, and spectroscopic
properties of [Fe(Porphyrin) (THF)2]ClO4 will be published elsewhere.
[Fe(TiPrP)(THF)2]ClO4 and [Fe(OETPP)(THF2)ClO4 turned out to be
(41) Ogoshi, H.; Sugimoto, H.; Watanabe, E.; Yoshida, Z.; Maeda, Y.;
Sakai, H.; Bull. Chem. Soc. Jpn. 1981, 54, 3414-3419.
(42) La Mar, G. N.; Gaudio, J. D.; Frye, J. S. Biochim. Biophys. Acta 1977,
498, 422-435.
(43) Nakamura, M.; Ikeue, T.; Ikezaki, A.; Ohgo, Y.; Fujii, H. Inorg. Chem.
1999, 38, 3857-3862.
3
very pure intermediate spin (S ) /2) complexes.40
(40) Ikeue, T.; Saitoh, T.; Yamaguchi, T.; Ohgo, Y.; Nakamura, M.;
Takahashi, M.; Takeda, M. Chem. Commun. 2000, 1989-1990.